People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Other, Medical Devices, Biotechnology, Other Health Care, Investment Vehicle
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Phenom People, Inc. | — | Other | Series B | $60.3M | $498.4M | 2018 |
| Run This Show Ltd Liability Co | — | Other | Series B | $25.0M | $159.1M | 2024 |
| Acuamark Diagnostics, Inc. | — | Medical Devices | Series A | $20.3M | $25.6M | 2019 |
| Labcyte Inc | — | Biotechnology | Series A | $10.8M | $180.8M | 2016 |
| Ocudyne, Inc. | — | Other Health Care | Series A | $10.1M | $21.9M | 2017 |
| Succeed on Broadway Ltd Liability Co | — | Other | Series A | $8.5M | $129.0M | 2011 |
| Parti Pris Investment Partners, Inc. | — | Investment Vehicle | Pre-Seed | $750K | $2.6M | 2024 |
Joseph Smith at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joseph Smith on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tim Guleri | 1 | 13 |
| Craig Taylor | 1 | 13 |
| Beth Williams | 1 | 12 |
| James L. Nederlander | 1 | 9 |
| Michael McCabe | 1 | 8 |
| John Gore | 1 | 6 |
| Stephen Johnson | 1 | 5 |
| Alex Scherbakovsky | 1 | 5 |
| Joseph D. Keegan | 1 | 4 |
| Neil Meron | 1 | 4 |
| Tom McGrath | 1 | 4 |
| Cedric Francois | 1 | 4 |
| Joe Keegan | 1 | 3 |
| Miles Wilkin | 1 | 3 |
| Gregory Murdock | 1 | 3 |
| Robert Atkinson | 1 | 3 |
| Brian Carr | 1 | 3 |
| Joseph H. Smith | 1 | 3 |
| Joseph M. Smith | 1 | 3 |
| Mark Fischer-Colbrie | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.